Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...

Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 NT219 data presented at ...

inhibits colorectal cancer brain metastasis through the IRS2 pathway IRS2, a novel target of NT219, is identified as a driver of brain metastasis in colorectal cancer, by comprehensive research ...

[2] The Low Resolution mode (LR) and the High Resolution mode (HR) are available on both IRS1 and IRS2 spectrographs while FMOS is still operated in a shared-risk mode. [3] Important for the ...

[Operational mode] From S12A, the High Resolution mode (HR) as well as the Low Resolution mode (LR) will be available on both IRS1 and IRS2. In S11B, LR will be available on both IRS1 and IRS2, while ...

Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 NT219 data presented ...

Purple Biotech Ltd. Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 ...

There is no Morningstar’s Analysis data available.